Wealth Enhancement Advisory Services, LLC Bristol Myers Squibb CO Transaction History

Wealth Enhancement Advisory Services, LLC

$49 Billion
Q1 2025

A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 550,613 shares of BMY stock, worth $27.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

550,613

Previous 470,526 17.02%

Holding current value

$27.4 Million

Previous $26.6 Million 26.19%

% of portfolio

0.07%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$53.9 - $63.11 $4.32 Million - $5.05 Million	80,087 Added 17.02%	550,613 $33.6 Million
Q4 2024 Mar 17, 2025	BUY	$51.92 - $59.94 $6.04 Million - $6.97 Million	116,365 Added 32.86%	470,526 $26.6 Million
Q4 2024 Jan 10, 2025	BUY	$51.92 - $59.94 $198,697 - $229,390	3,827 Added 1.09%	354,161 $20 Million
Q3 2024 Oct 23, 2024	SELL	$39.66 - $51.75 $2.37 Million - $3.09 Million	-59,666 Reduced 14.55%	350,334 $18.1 Million
Q2 2024 Jul 16, 2024	SELL	$40.25 - $52.99 $2.07 Million - $2.73 Million	-51,514 Reduced 11.16%	410,000 $17 Million
Q1 2024 Apr 15, 2024	BUY	$47.98 - $54.4 $3.57 Million - $4.05 Million	74,486 Added 19.25%	461,514 $25 Million
Q4 2023 Jan 30, 2024	SELL	$48.48 - $57.85 $3.34 Million - $3.98 Million	-68,850 Reduced 15.1%	387,028 $19.9 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $21 Million - $23.4 Million	362,065 Added 385.94%	455,878 $26.5 Million
Q2 2023 Jul 21, 2023	SELL	$63.71 - $70.74 $136,084 - $151,100	-2,136 Reduced 2.23%	93,813 $6 Million
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $6.3 Million - $7.15 Million	95,949 New	95,949 $6.65 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $3.64 Million - $4.13 Million	-63,110 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $3.62 Million - $4.02 Million	63,110 New	63,110 $3.9 Million
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $206,671 - $241,619	-3,770 Closed	0 $0
Q1 2020 May 01, 2020	SELL	$46.4 - $67.43 $1,392 - $2,022	-30 Reduced 0.79%	3,770 $234,000
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $186,998 - $243,922	3,800 New	3,800 $242,000
Q1 2018 Apr 26, 2018	SELL	$59.92 - $68.98 $436,936 - $503,002	-7,292 Closed	0 $0
Q4 2017 Jan 19, 2018	BUY	$59.94 - $65.35 $437,082 - $476,532	7,292	7,292 $458,000

Others Institutions Holding BMY

# of Institutions

2,782

Shares Held

1.56B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $106B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.

Account

Wealth Enhancement Advisory Services, LLC Bristol Myers Squibb CO Transaction History